Trial
NCT00478244
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Epidermolysis Bullosa
Intervention
busulfan
Why stopped
Competing studies
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28